GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rankning i aktier
#3666
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Aktiekurs
$27.17
Marknadsvärde
$4.60B
Förändring (1 dag)
-1.33%
Förändring (1 år)
-13.30%
Land
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Historik för aktiesplit för GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Aktien GlaxoSmithKline Pharmaceuticals Limited (symbol: GLAXO) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Sep 11, 2018.
En GLAXO-aktie köpt före Sep 11, 2018 motsvarar nu 2 GLAXO-aktier.
Den senaste spliten skedde den Sep 11, 2018.
En GLAXO-aktie köpt före Sep 11, 2018 motsvarar nu 2 GLAXO-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2018-09-11 | 2:1 | x2 | x2 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 4 | x15 |
US
|
|
| 7 | x432 |
US
|
|
| 0 | - |
US
|
|
| 7 | x226 |
US
|
|
| 2 | x10000 |
CH
|
